Page 2 - Alvogen Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NRx Pharmaceuticals Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

RADNOR - NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that the Company has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar.

United statesJonathan javittMatthew duffyAndrew nierenbergJeremy fefferExchange commissionLotus pharmaceuticals incTherapeutics incAlvogen incNrx pharmaceuticalsUs national institutes of healthNrx pharmaceuticals incSpecialty pharmaceutical companySecurities exchangeTreatment resistant bipolar depression studyBreakthrough therapy designation

NRx Pharma Achieves Data-lock In Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study

Biopharmaceutical company NRx Pharmaceuticals, Inc. (NRXP) announced Monday that it has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study with NRX-101.

Alvogen incLotus pharmaceuticals incNrx pharmaceuticals incTreatment resistant bipolar depression studyLotus pharmaceuticalsBreakthrough therapy designationFast track designationBiomarker letterSpecial protocol agreementSuicidal treatment resistant bipolar

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan javittAndrew nierenbergNrx pharmaceuticalsAlvogen incNrx pharmaceuticals incNrxp nrx pharmaceuticalsLotus pharmaceuticals incTreatment resistant bipolar depression studyLotus pharmaceuticalsBreakthrough therapy designationFast track designationBiomarker letterSpecial protocol agreementSuicidal treatment resistant bipolarSevere bipolar depression

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalMarion leboyerStephen willardMichael grunebaumMocrane abbarJanet rehnquistSecurities exchangeLotus pharmaceuticals incPrnewswire nrx pharmaceuticals incAlvogen incExchange commissionTherapeutics incNephron pharmaceuticals incCompany board of directorsCompany scientific leadership sappko

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

/PRNewswire/ NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announces.

United statesStephen willardTherapeutics incNrx pharmaceuticalsUs national institutes of healthUs patient centered outcomes research initiativeAlvogen incNephron pharmaceuticalsLotus pharmaceuticals incNrxp nrx pharmaceuticalsPrnewswire nrx pharmaceuticals incSpecialty pharmaceutical companyCompany board of directorsLotus pharmaceuticalsSuicidal bipolar depressionData lock